Categories
Thyrocare Technologies Limited — Updates, 07-05-2026: Press Release
07-05-2026 · 06:43 pm
Thyrocare reported robust Q4FY26 results: Revenue grew 20% YoY to ₹223.95 Cr, EBITDA rose 31% to ₹75.09 Cr, and PAT surged 128% to ₹48.70 Cr. The company expanded into specialty diagnostics, including allergy testing and genomics.
No comments yet. Be the first to comment!